LSP holds USD280 million final closing of life sciences venture fund
LSP (Life Sciences Partners), the European life sciences investment group, has held the final closing of its new life sciences fund, LSP 5. The fund surpassed its USD170 million target and reached the ‘hard cap’ of USD280 million, making LSP 5 one of the largest life sciences funds in Europe.
